Bullous Pemphigoid: Clinical and Immunologic Follow-up After Successful Therapy

Archives of Dermatology

Volumn 113, Issue 8, 1977, Pages 1043-1046

  Ahmed, A Razzaque ^a,b   Maize, John C ^a   Provost, Thomas T ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; BASEMENT MEMBRANE ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE;

BASEMENT MEMBRANE; DRUG THERAPY; PEMPHIGOID; THERAPY;

ADULT; AGED; AZATHIOPRINE; BASEMENT MEMBRANE; COMPLEMENT 3; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMAN; IMMUNOGLOBULINS; MALE; MIDDLE AGE; PREDNISONE; RECURRENCE; SKIN DISEASES, VESICULOBULLOUS; SUPPORT, U.S. GOV'T, P.H.S.; TRIAMCINOLONE ACETONIDE;

EID: 0017683407     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1977.01640080045002     Document Type: Article

References (24)

1. Lever WF: Pemphigus. Medicine 32:1-123, 1953.
2. Jordon RE, Beutner EH, Witebsky E, et al: Basement zone antibodies in bullous pemphigoid. JAMA 200:751-756, 1967.
3. Chorzelski T, Jablonska S, Blaszcsyk M: Autoantibodies in pemphigoid. Dermatologica 136:325-334, 1968.
4. Jordon RE, Trifthauser CT, Schroeter AL: Direct immunofluorescence studies of pemphigus and pemphigoid. Arch Dermatol 103:486-491, 1971.
5. Jordon RE, Sams WM Jr, Beutner EH: Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med 74:548-556, 1969.
6. Cormane RH, Szabo E: Immunopathology of skin in pemphigoid. Br J Dermatol 83:435-445, 1970.
7. Beutner EH, Jordon RE, Chorzelski TP: Immunopathology of pemphigus and pemphigoid. J Invest Dermatol 51:65-80, 1968.
8. Provost TT, Tomasi TB Jr: Immunopathology of bullous pemphigoid. Clin Exp Immunol 18:193-200, 1974.
9. Jordon RE, Schroeter AL, Good RA, et al: Complement system in bullous pemphigoid. Clin Immunol Immunopathol 3:307-314, 1975.
10. Sams WM Jr, Jordon RE: Correlation of pemphigoid and pemphigus antibody titers with disease activity. Br J Dermatol 84:7-13, 1971.
11. Peck SM, Osserman KE, Weiner LB, et al: Studies in bullous disease. N Engl J Med 279:951-958, 1968.
12. Sams WM Jr, Gleich GJ: Failure to transfer bullous pemphigoid with serum from patients. Proc Soc Exp Biol Med 136:1027-1031, 1971.
13. Brennan JG, Montgomery H: Pemphigus and other bullous dermatoses: Correlation of clinical and pathological findings: J Invest Dermatol 211:349-363, 1953.
14. Lever WF: Pemphigus and Pemphigoid. Springfield, Ill, Charles C Thomas Publisher, 1965.
15. Rook A, Waddington E: Pemphigus and pemphigoid. Br J Dermatol 64:425-438, 1953.
16. Stevenson CJ: Treatment in bullous dermatoses with corticosteroids, drugs and corticotrophin. Br J Dermatol 72:11-19, 1960.
17. Church R: Pemphigoid treated with corticosteroids. Br J Dermatol 72:434-441, 1960.
18. Ruddy S, Gigli I, Austen KF: The complement system of man. N Engl J Med 287:489-495, 545-549, 592-596, 1972.
19. Cormane RH, Giannetti A: IgD in various dermatoses: Immunofluorescence studies. Br J Dermatol 84:523-533, 1971.
20. Greaves MW, Burton JL, Marks J, et al: Azathioprine in treatment of bullous pemphigoid. Br Med J 1:144-145, 1971.
21. Van Dijk TJA, Van Velde JL: Treatment of pemphigus and pemphigoid with azathioprine. Dermatologica 147:179-185, 1973.
22. Provost TT, Tomasi TB Jr: Evidence for complement activation via the alternate pathway in skin diseases: I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest 52:1779-1787, 1973.
23. Jordon RE, Heine KG, Tappeiner G, et al: The immunopathology of herpes gestationis: Immunofluorescence studies and characterization of “HG factor”. J Clin Invest 57:1426-1433, 1976.
24. Katz SI, Hertz KC, Yaoita H: Herpes gestationis. Immunopathology and characterization of HG factor. J Clin Invest 57:1434-1441, 1976.